Findings

What do systematic reviews say?

3 questions · 3 findings · 2 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 33.3%Low 0 · 0%Moderate 1 · 33.3%High 1 · 33.3%

All‐cause mortality · people hospitalised with COVID‐19

It is very uncertain whether anticoagulants changes all‐cause mortality compared with no treatment (very low certainty).

1 finding from 1 review

Anticoagulants for people hospitalised with COVID‐19: a rapid review 2022 · Cochrane Headline outcomes only
RR 0.64 [0.55, 0.74]
3 studies · 8395 participants
Very low

All‐cause mortality · people hospitalised with COVID‐19

Higher‐dose anticoagulants showed no clear difference in all‐cause mortality compared with lower‐dose anticoagulants (high certainty).

1 finding from 1 review

Anticoagulants for people hospitalised with COVID‐19: a rapid review 2022 · Cochrane Headline outcomes only
RR 1.03 [0.92, 1.16]
4 studies · 4489 participants
High

All‐cause mortality · atrial fibrillation patients with CKD

Direct oral anticoagulants (DOAC) showed no clear difference in all‐cause mortality compared with warfarin (moderate certainty).

1 finding from 1 review